Following these proceedings, UBS reiterated its Cumberland Pharmaceuticals Inc [CPIX] rating to a Neutral in a research note published on November 12, 2012; the price target was $5. A number of analysts have revised their coverage, including UBS’s analysts, who remained covering the stock and in early February has reiterated a ‘”a Neutral”‘ rating for it. UBS also remained covering CPIX and has decreased its forecast on December 16, 2010 with a “Neutral” recommendation from previously “Buy” rating. UBS maintained its rating on August 17, 2010. It rated CPIX as “a Buy”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of CPIX
On Tuesday, Cumberland Pharmaceuticals Inc [NASDAQ:CPIX] saw its stock jump 96.77% to $2.44. Over the last five days, the stock has gained 95.20%. Cumberland Pharmaceuticals Inc shares have risen nearly 36.18% since the year began. Nevertheless, the stocks have risen 46.99% over the past one year. While a 52-week high of $2.36 was reached on 12/10/24, a 52-week low of $1.04 was recorded on 11/25/24. SMA at 50 days reached $1.2400, while 200 days put it at $1.4700.
Levels Of Support And Resistance For CPIX Stock
The 24-hour chart illustrates a support level at 2.0800, which if violated will result in even more drops to 1.7300. On the upside, there is a resistance level at 2.9200. A further resistance level may holdings at 3.4100. The Relative Strength Index (RSI) on the 14-day chart is 85.95, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.3500, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 30.35%. Stochastics %K at 47.16% indicates the stock is a holding.
How much short interest is there in Cumberland Pharmaceuticals Inc?
A steep rise in short interest was recorded in Cumberland Pharmaceuticals Inc stocks on 2024-11-29, growing by 87571.0 shares to a total of 0.16 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 76744.0 shares. There was a rise of 53.29%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 17, 2010 when Morgan Joseph resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $10.
